WHC is still in active development. Read this to understand our approach.
depiction of DHHVAGZRUROJKS-UHFFFAOYSA-N.svg
tripsit

phentermine

Verificar en tripsit

isomerdesign

Phentermine

Verificar en isomerdesign

pubchem

Phentermine

Verificar en pubchem

drugmap

Phentermine

Verificar en drugmap

wiki

Phentermine

Verificar en wiki

Data

InChI: InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3

Sinónimos: Phenethylamine, alpha,alpha-dimethyl-,BRD-K96319534-001-01-7, Normephentermine,PHENTERMINE COMPONENT OF QSYMIA, Adipex-P, Ionamin,Phentrol 2,PHENTERMINE [WHO-DD],D05458,1,1-Dimethyl-2-phenylethylamine, Fentermina,Linyl,122-09-8,Mirapront, Phentremene (TN), Teramine (TN), Obestin-30 (TN),SR-05000001805-2,DTXSID9023461,Phentermine (USAN/INN), Lonamin, 1-(2-Tolyl)-2-propylamine,Ethanamine, 1,1-dimethyl-2-phenyl-, Phentermine Resin 30,alpha,alpha-Dimethylphenethylamine, Omnibex,.alpha.,.alpha.-Dimethylphenethylamine, Zantryl (TN),alpha-Benzylisopropylamine, Phentercot, Umine (TN),FT-0716831,SCHEMBL26615, Lipopill, Inoamin, Ona Mast,Lipopill,C045TQL4WP,AKOS004123261,2-Amino-2-methyl-1-phenylpropane,Benzeneethanamine, .alpha.,.alpha.-dimethyl-,Ionamin, Linyl,alpha,alpha-Dimethyl-beta-phenylethylamine,Phentrol 3,Phenyl-tert-butylamine, Fastin (TN),PHENTERMINE [HSDB],Phentermine [USAN:INN:BAN],alpha,alpha-Dimethylbenzeneethanamine,Obermine, Oby-Trim, Ionamin (TN), Fastin, 1,1-Dimethyl-2-phenylethylamine, Fentermina [INN-Spanish],alpha,alpha-Dimethylphenethylamine solution,HMS2093B16, Obenix, Obermine,Phentermine resin complex, Pro-Fast,Fentermina [INN-Spanish], Phentermine [USAN:INN:BAN],SR-05000001805-1,Phenyl-tertiary-butylamine,PHENTERMINE [MART.], Phentermine (TN),NSC-759163, 2-Amino-2-methyl-1-phenylpropane, (alpha,alpha)-Dimethylphenethylamine, Phentrol 3,GTPL7269,DB00191, Phentermine HCl,BDBM50246598, Duromine (TN),Phentermine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Adipex P (TN),QSYMIA COMPONENT PHENTERMINE,Phentermine 1.0 mg/ml in Methanol,EINECS 204-522-1, Wilpo,DEA No. 1640,Duromine, Phenyl-tert-butylamine,BRN 0970319,2-Methyl-1-phenylpropan-2-amine,122-09-8 (free base), Redusa (TN), Trenker (TN), 2-Methyl-1-phenyl-2-propanamine, Phentride,ZINC8403947,RCRA waste no. P046, Mirapront, Alpha,alpha-Dimethyl-beta-phenylethylamine,Pharmakon1600-01505660,Benzeneethanamine, alpha,alpha-dimethyl-,PHENTERMINE [VANDF],RCRA waste number P046,NSC759163, Panbesy (TN), Alpha.,.alpha.-dimethyl-Benzeneethanamine, Phenterminum [INN-Latin], Ortetamina, Pro-Fast SA (TN),Adipex-P,Lonamin,Phenterminum [INN-Latin],Fentermina, Zantryl, Alpha-Benzylisopropylamine, Obenix (TN),phentermine,Phentrol, AmbkkkkK744, Ortetamin, Phentermine (USAN/INN), Phenyl-tertiary-butylamine, Alpha,alpha-Dimethylphenethylamine,PHENTERMINE [MI], Ortetaminum,α,α-Dimethylphenethylamine,Phentermine resin, Phentrol 4, Phentrol 2,NSC 759163,EC 204-522-1,CHEBI:8080,Phentermine, Phenterex (TN),Phenethylamine, .alpha.,.alpha.-dimethyl-,α,α-Me-PEA, 2-Phenyl-tert-butylamine, Supremin (TN),Phentrol 4, Phentromin (TN), Phentrol (TN), Anoxine-AM (TN), Ortetamine [INN], Ionamine, Obermine (TN),SR-05000001805,Normephentermine,SBI-0206817.P001, Sinpet (TN),Omnibex, 1-(2-Methylphenyl)-2-propylamin,1,1-DIMETHYL-2-PHENYL-ETHYLAMINE,AB02355, Obephen (TN), Alpha,alpha-Dimethylbenzeneethanamine,Phenterminum,Qsiva,2-methyl-1-phenylpropan-2-amine,HSDB 3158,C07438,UNII-C045TQL4WP,PHENTERMINE [INN],Phentermine 0.1 mg/ml in Methanol,.alpha..alpha.Dimethylphenethylamine, Phenterminum, Phentermine resin complex,NCGC00263911-02,PHENTERMINE [USAN], Oby-Trim (TN),D1291,Q418157,2-Phenyl-tert-butylamine, Weltmine (TN),(alpha,alpha)-Dimethylphenethylamine, Mirapront (TN), Phentrol,CHEMBL1574,1-benzyl-iso-propyl amine

Estimated data

Solubilidad: -1.094 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 83.4% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.